Author

Michelle Bradbury

Institutions: University of Ottawa, Juravinski Cancer Centre, Ottawa Hospital, Ottawa Hospital Research Institute, McMaster University

Observed institutions: University of Ottawa, Juravinski Cancer Centre, Ottawa Hospital, Ottawa Hospital Research Institute, McMaster University

OpenAlex ID: A5037004155

Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review

2021 · Michelle Bradbury, Brian Hutton, et al. · Clinical Breast Cancer · 41

Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen

2025 · Zainab Al Maqrashi, Michelle Bradbury, et al. · Future Science OA · 3

Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience

2025 · Michelle Bradbury, Adam Gabara, et al. · Immunotherapy · 3

Clinicopathological features of pulmonary mucinous adenocarcinoma: A descriptive analysis

2022 · Michelle Bradbury, Deborah Akurang, et al. · Cancer Treatment and Research Communications · 3

Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?

2025 · Ana-Alicia Beltran-Bless, Igor de Lima Machada, et al. · Breast Cancer Research and Treatment · 2

Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery

2024 · Parvaneh Fallah, Lucas Clemons, et al. · Current Oncology · 2

Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective

2023 · Michelle Bradbury, Marie-France Savard, et al. · Current Oncology · 1

Works count: 9

Citation count: 55

H-index: 3

I10-index: 1